CymitQuimica logo
Metabolism

Metabolism

Metabolism inhibitors are compounds that interfere with metabolic pathways, altering the production and utilization of energy within cells. These inhibitors are used to study the regulation of metabolism, the role of metabolic pathways in diseases like cancer and diabetes, and to develop new therapeutic strategies. Metabolism inhibitors can target various enzymes and processes involved in glycolysis, fatty acid oxidation, and other metabolic functions. At CymitQuimica, we offer a wide range of high-quality metabolism inhibitors to support your research in biochemistry, metabolic disorders, and drug development.

Subcategories of "Metabolism"

Show 34 more subcategories

Found 9154 products of "Metabolism"

Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • CJ-13,610
    Targetmol
    + Info

    CJ-13,610

    CAS:
    CJ-13,610 is an orally active and nonredox-type inhibitor of 5-lipoxygenase (5-LOX). CJ-13,610 inhibits the biosynthesis of leukotriene B4 and regulates the expression of IL-6 mRNA in macrophages.
    Formula:C22H23N3O2S
    Purity:99.64%
    Color and Shape:Solid
    Molecular weight:393.5

    Ref: TM-T27026

    1mg
    Discontinued
    Discontinued product
  • CC15009
    Targetmol
    + Info

    CC15009

    CAS:

    CC15009 is a potent inhibitor of xanthine oxidoreductase (XOR), demonstrating an IC50 value of 0.237 nM. It effectively inhibits the oxidative subtype of XOR, thereby reducing the generation of the byproduct ROS and exhibiting antioxidant activity. CC15009 has shown a favorable dose-dependent uric acid-lowering effect in two different XOR substrate-induced hyperuricemia mouse models.

    Formula:C20H21Cl2N5O2
    Color and Shape:Solid
    Molecular weight:434.32

    Ref: TM-T200445

    10mg
    Discontinued
    25mg
    Discontinued
    50mg
    Discontinued
    100mg
    Discontinued
    Discontinued product
  • SH1573
    Targetmol
    + Info

    SH1573

    CAS:

    SH1573 is an orally active inhibitor of mutant isocitrate dehydrogenase 2 (mIDH2). It selectively targets the mIDH2 R140Q protein with a potent inhibitory effect (IC50=4.78 nmol/L), significantly reducing the production of the oncogenic metabolite 2-hydroxyglutarate (2-HG) in animal models, cell lines, serum, and tumors. SH1573 is utilized in the study of acute myeloid leukemia (AML).

    Formula:C21H18F9N7O4S
    Color and Shape:Solid
    Molecular weight:635.46

    Ref: TM-T200209

    10mg
    Discontinued
    25mg
    Discontinued
    50mg
    Discontinued
    100mg
    Discontinued
    Discontinued product
  • CymitQuimica logo
    Targetmol
    + Info

    ZK824859 hydrochloride

    ZK824859 hydrochloride: oral uPA inhibitor with IC50 of 79 nM (uPA), 1580 nM (tPA), 1330 nM (fibrin).
    Formula:C23H23ClF2N2O4
    Color and Shape:Solid
    Molecular weight:464.89

    Ref: TM-T62961

    25mg
    Discontinued
    50mg
    Discontinued
    100mg
    Discontinued
    Discontinued product